Presentation is loading. Please wait.

Presentation is loading. Please wait.

Adolescent Stakeholders Meeting Outline  Goals of meeting (5 min.)  Key strategies and issues (40 min.)  Venues, duration, and dates (10 min.)  Stakeholders.

Similar presentations


Presentation on theme: "Adolescent Stakeholders Meeting Outline  Goals of meeting (5 min.)  Key strategies and issues (40 min.)  Venues, duration, and dates (10 min.)  Stakeholders."— Presentation transcript:

1 Adolescent Stakeholders Meeting Outline  Goals of meeting (5 min.)  Key strategies and issues (40 min.)  Venues, duration, and dates (10 min.)  Stakeholders (5 min.)  Organizing committee (10 min.)

2 Adolescent Stakeholders Meeting Outline  Goals of meeting (5 min.)  Key strategies and issues (40 min.)  Venues, duration, and dates (10 min.)  Stakeholders (5 min.)  Organizing committee (10 min.)

3 Adolescent Stakeholders Meeting Outline  Goals of meeting (5 min.)  Key strategies and issues (40 min.)  Venues, duration, and dates (10 min.)  Stakeholders (5 min.)  Organizing committee (10 min.)

4 Adolescent Stakeholders Meeting Provisional Goals  Identify the strengths and weaknesses of key implementation strategies and issues  Identify approaches that will effectively and efficiently increase the proportion of adolescents who receive vaccines  Develop plans to implement these approaches  Identify research initiatives – Support the successful introduction – Accelerate development of vaccines in the 'pipeline'

5 Adolescent Stakeholders Meeting Key Strategies and Issues A. Delivery systems and settings B. Integration with other adolescent health priorities C. Financing and other important barriers D. Consent E. Appropriate roles and responsibilities (local, state, and federal) F. Novel vaccine delivery systems G. Immunization regulations and other mandates H. Communications strategies

6 Adolescent Stakeholders Meeting Key Strategy/Issue A  In which combination of delivery systems and settings can the new adolescent vaccines best be implemented? – Primary health care providers – Non-traditional health care providers – Schools  Voluntary school based programs and  Vaccination as a requirement for school entry

7 Adolescent Stakeholders Meeting Key Strategy/Issue B  How can vaccination be integrated with other adolescent health priorities? – Prevention of unintentional injuries  Motor vehicle accidents – Prevention of intentional injuries  Homicide  Suicide – Prevention of drug and alcohol use

8 Adolescent Stakeholders Meeting Key Strategy/Issue C  How should vaccination efforts be financed?  Which other barriers at are most important to the health care system, providers, and patients? – e.g. missed opportunities, lack of knowledge (patients and providers)

9 Adolescent Stakeholders Meeting Key Strategy/Issue D  Are there new approaches to obtaining consent? – What laws enable minors to consent to treatment and prevention services in the U.S.? – What is the current and potential use of these laws to enable self-consent for adolescent immunization? – Can a single consent be flexible, e.g. covering multiple vaccinations with a single consent form?

10 Adolescent Stakeholders Meeting Key Strategy/Issue E  What are the appropriate roles and responsibilities of local, state, and federal public health officials? – Local  e.g. Should schools be involved? – State  e.g. Are mandates advisable? – Federal  e.g. Plan for national implementation?

11 Adolescent Stakeholders Meeting Key Strategy/Issue F  What is the role of novel vaccine delivery systems (i.e., needle-less systems) for delivery of vaccines to adolescents?

12 Adolescent Stakeholders Meeting Key Strategy/Issue G  When and how should immunization regulations and other mandates be used to increase the uptake of new vaccines? – Are mandates essential for equity? – What are the public health policy implications of recommendations in the absence of mandates? – Should there be federal guidance on what vaccines should be subject to mandates?  What laws best serve the public?  What is the appropriate role for pharmaceutical companies?

13 Adolescent Stakeholders Meeting Key Strategy/Issue H  What communications strategies are most appropriate and effective? – How should parents be informed?  Direct to consumer marketing?  Providers?  Physicians?

14 Adolescent Stakeholders Meeting Outline  Goals of meeting (5 min.)  Key strategies and issues (40 min.)  Venues, duration, and dates (10 min.)  Stakeholders (5 min.)  Organizing committee (10 min.)

15 Adolescent Stakeholders Meeting Venues, Duration, and Dates  Washington, DC  Dates (2 day periods) – March 14-15, 15-16, 16-17, 28-29 – May 12-13, 18-19, 19-20 – June 1-2, 2-3, 3-4, 20-21, 21-22, 22-23, 23- 24, 27-28

16 Adolescent Stakeholders Meeting Outline  Goals of meeting (5 min.)  Key strategies and issues (40 min.)  Venues, duration, and dates (10 min.)  Stakeholders (5 min.)  Organizing committee (10 min.)

17 Adolescent Stakeholders Meeting Outline  Goals of meeting (5 min.)  Key strategies and issues (40 min.)  Venues, duration, and dates (10 min.)  Stakeholders (5 min.)  Organizing committee (10 min.) – Key strategies and issues – Vaccines  N. meningitidis conjugate  Tdap  HPV  HSV  CMV  HIV – Organization


Download ppt "Adolescent Stakeholders Meeting Outline  Goals of meeting (5 min.)  Key strategies and issues (40 min.)  Venues, duration, and dates (10 min.)  Stakeholders."

Similar presentations


Ads by Google